IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CHRISTY LAN MA

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant

NPI
1902379290
CMS profile
10635263
Location
SALT LAKE CITY, UT

General Payments · PY2021–2024

$14,694.60

  • Reported across 86 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$11,115.46

49 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Physician Assistant UT All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $6,747.50 5
Food and Beverage $2,601.93 37
Travel and Lodging $1,696.04 6
Education $69.99 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Actelion Pharmaceuticals US, Inc. $8,202.03 31
Novo Nordisk AS $1,320.00 2
United Therapeutics Corporation $826.90 9
Bayer HealthCare Pharmaceuticals Inc. $200.00 1
Amgen Inc. $121.84 1
Lexicon Pharmaceuticals, Inc. $121.69 1
Braeburn Inc. $115.14 1
Kiniksa Pharmaceuticals International, plc $101.21 1
Merck Sharp & Dohme Corporation $72.01 1
Sandoz Inc. $34.64 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $287.07 7
PY2022 $600.81 6
PY2023 $2,691.26 24
PY2024 $11,115.46 49

Payment records · PY2024 (49)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Actelion Pharmaceuticals US, Inc. $81.43 01/04/2024 Food and Beverage Undisputed 01/23/2026 1078921037 CMS
Actelion Pharmaceuticals US, Inc. $14.42 05/28/2024 Food and Beverage Undisputed 01/23/2026 1078921029 CMS
Actelion Pharmaceuticals US, Inc. $34.13 06/06/2024 Food and Beverage Undisputed 01/23/2026 1078920775 CMS
Actelion Pharmaceuticals US, Inc. $95.04 06/26/2024 Food and Beverage Undisputed 01/23/2026 1078920693 CMS
Actelion Pharmaceuticals US, Inc. $69.99 06/26/2024 Education Undisputed 01/23/2026 1078920909 CMS
Actelion Pharmaceuticals US, Inc. $21.80 06/26/2024 Food and Beverage Undisputed 01/23/2026 1078921055 CMS
Actelion Pharmaceuticals US, Inc. $120.07 07/11/2024 Food and Beverage Undisputed 01/23/2026 1078920951 CMS
Actelion Pharmaceuticals US, Inc. $597.59 07/19/2024 Travel and Lodging Undisputed 01/23/2026 1078920677 CMS
Actelion Pharmaceuticals US, Inc. $256.23 08/14/2024 Travel and Lodging Undisputed 01/23/2026 1078921069 CMS
Actelion Pharmaceuticals US, Inc. $23.22 08/15/2024 Food and Beverage Undisputed 01/23/2026 1078920881 CMS
Actelion Pharmaceuticals US, Inc. $42.09 08/15/2024 Food and Beverage Undisputed 01/23/2026 1078921023 CMS
Actelion Pharmaceuticals US, Inc. $45.00 08/15/2024 Food and Beverage Undisputed 01/23/2026 1078921039 CMS
Actelion Pharmaceuticals US, Inc. $49.94 08/15/2024 Food and Beverage Undisputed 01/23/2026 1078921059 CMS
Actelion Pharmaceuticals US, Inc. $50.31 08/17/2024 Food and Beverage Undisputed 01/23/2026 1078920945 CMS
Actelion Pharmaceuticals US, Inc. $2,050.00 08/27/2024 Consulting Fee Undisputed 01/23/2026 1078920741 CMS
Actelion Pharmaceuticals US, Inc. $11.18 09/10/2024 Food and Beverage Undisputed 01/23/2026 1078920797 CMS
Actelion Pharmaceuticals US, Inc. $65.00 09/10/2024 Food and Beverage Undisputed 01/23/2026 1078920975 CMS
Actelion Pharmaceuticals US, Inc. $29.89 09/10/2024 Travel and Lodging Undisputed 01/23/2026 1078920977 CMS
Actelion Pharmaceuticals US, Inc. $39.78 10/30/2024 Food and Beverage Undisputed 01/23/2026 1078920877 CMS
Actelion Pharmaceuticals US, Inc. $150.00 11/06/2024 Food and Beverage Undisputed 01/23/2026 1078920695 CMS
Actelion Pharmaceuticals US, Inc. $60.00 11/06/2024 Food and Beverage Undisputed 01/23/2026 1078920747 CMS
Actelion Pharmaceuticals US, Inc. $80.00 11/06/2024 Food and Beverage Undisputed 01/23/2026 1078920785 CMS
Actelion Pharmaceuticals US, Inc. $60.00 11/06/2024 Food and Beverage Undisputed 01/23/2026 1078921071 CMS
Actelion Pharmaceuticals US, Inc. $258.77 11/06/2024 Travel and Lodging Undisputed 01/23/2026 1078921115 CMS
Actelion Pharmaceuticals US, Inc. $437.87 11/06/2024 Travel and Lodging Undisputed 01/23/2026 1078921145 CMS
Actelion Pharmaceuticals US, Inc. $60.41 11/08/2024 Food and Beverage Undisputed 01/23/2026 1078920639 CMS
Actelion Pharmaceuticals US, Inc. $115.69 11/08/2024 Travel and Lodging Undisputed 01/23/2026 1078920779 CMS
Actelion Pharmaceuticals US, Inc. $15.00 11/08/2024 Food and Beverage Undisputed 01/23/2026 1078920787 CMS
Actelion Pharmaceuticals US, Inc. $3,177.50 11/25/2024 Consulting Fee Undisputed 01/23/2026 1078920941 CMS
Actelion Pharmaceuticals US, Inc. $37.08 12/05/2024 Food and Beverage Undisputed 01/23/2026 1078921129 CMS
Actelion Pharmaceuticals US, Inc. $52.60 12/07/2024 Food and Beverage Undisputed 01/23/2026 1078920671 CMS
Amgen Inc. $121.84 02/28/2024 Food and Beverage Undisputed 01/23/2026 1115888761 CMS
Bayer Healthcare Pharmaceuticals Inc. $200.00 09/23/2024 Consulting Fee Undisputed 01/23/2026 1086321304 CMS
Braeburn Inc. $115.14 03/05/2024 Food and Beverage Undisputed 01/23/2026 1125611817 CMS
Kiniksa Pharmaceuticals International, plc $101.21 07/25/2024 Food and Beverage Undisputed 01/23/2026 1154872215 CMS
Lexicon Pharmaceuticals, Inc. $121.69 02/08/2024 Food and Beverage Undisputed 01/23/2026 1081709829 CMS
Merck Sharp & Dohme LLC $72.01 10/15/2024 Food and Beverage Undisputed 01/23/2026 1141761161 CMS
Novo Nordisk Inc $660.00 12/12/2024 Consulting Fee Undisputed 01/23/2026 1100658526 CMS
Novo Nordisk Inc $660.00 12/13/2024 Consulting Fee Undisputed 01/23/2026 1100492063 CMS
Sandoz Inc. $34.64 01/31/2024 Food and Beverage Undisputed 01/23/2026 1089366716 CMS
United Therapeutics Corporation $99.80 02/06/2024 Food and Beverage Undisputed 01/23/2026 1149450583 CMS
United Therapeutics Corporation $50.76 07/24/2024 Food and Beverage Undisputed 01/23/2026 1149455502 CMS
United Therapeutics Corporation $121.65 08/20/2024 Food and Beverage Undisputed 01/23/2026 1149469610 CMS
United Therapeutics Corporation $121.84 08/28/2024 Food and Beverage Undisputed 01/23/2026 1149463386 CMS
United Therapeutics Corporation $118.20 09/18/2024 Food and Beverage Undisputed 01/23/2026 1149457350 CMS
United Therapeutics Corporation $16.50 10/22/2024 Food and Beverage Undisputed 01/23/2026 1149457360 CMS
United Therapeutics Corporation $128.75 10/22/2024 Food and Beverage Undisputed 01/23/2026 1149471410 CMS
United Therapeutics Corporation $84.70 11/05/2024 Food and Beverage Undisputed 01/23/2026 1149458472 CMS
United Therapeutics Corporation $84.70 12/11/2024 Food and Beverage Undisputed 01/23/2026 1149459318 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.